Partial Pleurectomy for Mesothelioma

This trial examines whether a surgery called partial pleurectomy, which removes the lining of the lungs, can improve symptoms and quality of life for individuals with pleural mesothelioma—a type of lung cancer that cannot be fully removed. Researchers aim to understand the surgery's effects on symptoms, any complications, and the time required before starting other treatments. Individuals diagnosed with the epithelioid subtype of pleural mesothelioma, with the disease confined to one side of the chest, and who have completed certain cancer treatments might be suitable candidates for this trial.

As an unphased trial, this study provides a unique opportunity to contribute to medical knowledge and potentially enhance future treatment options.

The trial information does not specify if you need to stop taking your current medications. However, it mentions that participants must have completed at least 6 weeks of systemic induction therapy without unresolved adverse events before surgery. It's best to discuss your specific medications with the trial team.

Previous studies have shown that pleurectomy, a surgery to remove the lung lining, is generally safe for people with pleural mesothelioma, a type of lung cancer. Research indicates that this surgery is safe when doctors carefully select patients based on their overall health.

Doctors have performed the surgery on many individuals and found it can usually proceed without serious problems. However, like any surgery, risks and complications can occur, but these are typically manageable with careful patient selection.

Partial pleurectomy is unique because it offers a surgical approach specifically targeted at removing part of the pleura affected by mesothelioma, which is often considered unresectable. Unlike traditional treatments like chemotherapy and radiation, which aim to shrink or control tumors, partial pleurectomy directly removes the diseased tissue, potentially reducing tumor burden more effectively. Researchers are excited about this procedure because it could improve patients' quality of life by relieving symptoms such as fluid buildup and breathing difficulties, offering a more immediate and tangible benefit compared to other modalities.

Research has shown that a partial pleurectomy, a surgery to remove the lining around the lungs, can benefit people with pleural mesothelioma that cannot be fully removed. Studies have found that patients undergoing this lung-sparing surgery tend to live about 34 months on average. Specifically, one study found that patients with mesothelioma who had surgery lived about 21.7 months on average, compared to 13.6 months for those who did not undergo surgery. This suggests that the surgery might extend patients' lives. Additionally, the procedure can help manage symptoms and improve the quality of life for those affected. Participants in this trial will all receive a partial pleurectomy as part of the study procedures.¹²⁵⁶⁷